Head-to-Head Research Peptide Comparison Matrix & EU Supplier Audit
Compare receptor targets, CAS registry numbers, molecular weights, reconstitution solvents, and active batch release lots across Europe's most investigated research compounds—alongside an objective 2026 laboratory procurement audit checklist for Switzerland and the EU.
Incretin & Amylin Agonists Comparison Matrix
Head-to-head biochemical profile of mono-, dual-, and triple-receptor metabolic peptides (GLP-1R, GIPR, GCGR, Amylin)
| Compound | CAS # | Molecular Weight | Primary Receptor / Mechanism | Solvent | Active Lot / Spec | Unit (EUR) |
|---|---|---|---|---|---|---|
| Semaglutide 5 mg | 910463-68-2 | 4113.58 g/mol | Selective Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonist | Sterile 0.9% Bacteriostatic Water or sterile neutral PBS (pH 7.4) | SL-2026-154 ≥99.2% | €62 |
| Tirzepatide 10 mg | 2023788-19-2 | 4813.45 g/mol | Dual GIP Receptor (GIPR) & GLP-1 Receptor (GLP-1R) Co-Agonist | Sterile 0.9% Bacteriostatic Water or sterile PBS (pH 7.4) | SL-2026-165 ≥99.2% | €76 |
| Retatrutide 10 mg | 2381089-83-2 | 4731.33 g/mol | Triple GIP Receptor (GIPR), GLP-1R & Glucagon Receptor (GCGR) Agonist | Sterile 0.9% Bacteriostatic Water or sterile PBS (pH 7.4); swirl gently | SL-2026-152 ≥99.2% | €92 |
| Survodutide 5 mg | 2805997-46-8 | 4231.65 g/mol | Dual Glucagon Receptor (GCGR) & GLP-1 Receptor (GLP-1R) Agonist | Sterile 0.9% Bacteriostatic Water or sterile neutral PBS (pH 7.4) | SL-2026-160 ≥99.0% | €82 |
| Mazdutide 5 mg | 2259884-03-0 | 4563.06 g/mol | Dual GLP-1 Receptor (GLP-1R) & Glucagon Receptor (GCGR) Agonist | Sterile 0.9% Bacteriostatic Water or sterile PBS (pH 7.4) | SL-2026-143 ≥99.0% | €78 |
| Cagrilintide 5 mg | 1415456-99-3 | 4409.04 g/mol | Amylin receptors (AMY1R–AMY3R) & Calcitonin receptor (CTR) | Sterile 0.9% Bacteriostatic Water or sterile neutral saline; dissolve gently | SL-2026-114 ≥99.0% | €64 |
Tissue Repair & Inflammatory Pathway Comparison
Angiogenesis, actin-sequestration, melanocortin anti-inflammatory, and copper-chelated extracellular matrix peptides
| Compound | CAS # | Molecular Weight | Primary Receptor / Mechanism | Solvent | Active Lot / Spec | Unit (EUR) |
|---|---|---|---|---|---|---|
| BPC-157 5 mg | 137525-51-0 | 1419.53 g/mol | VEGFR2 / Akt-eNOS pathway, FAK-paxillin & growth hormone receptor expression | Sterile 0.9% Bacteriostatic Water or sterile PBS (pH 7.4) up to 10 mg/mL | SL-2026-110 ≥99.2% | €38 |
| TB-500 10 mg | 77591-33-4 | 4963.50 g/mol | Monomeric G-Actin sequestration, cell motility & angiogenesis | Sterile 0.9% Bacteriostatic Water (2.0 mL); gently roll vial, do not vortex | SL-2026-161 ≥99.0% | €48 |
| KPV 10 mg | 67727-97-3 | 342.43 g/mol | NF-κB nuclear translocation & PepT1-mediated mucosal inflammatory pathways | Sterile 0.9% Bacteriostatic Water or sterile PBS (>20 mg/mL) | SL-2026-138 ≥99.0% | €42 |
| GHK-Cu 50 mg | 49557-75-7 | 403.93 g/mol | Extracellular matrix remodeling (Collagen I/III, Decorin, MMP/TIMP) & broad gene modulation | Sterile 0.9% Bacteriostatic Water or sterile saline (yields vivid clear blue solution) | SL-2026-124 ≥99.2% | €46 |
| ARA 290 16 mg | 1208243-50-8 | 1257.31 g/mol | Innate Repair Receptor (EPOR / β-common receptor heteromer) | Sterile PBS (pH 7.4) or sterile 0.9% Bacteriostatic Water | SL-2026-107 ≥99.0% | €52 |
| Glow Blend 70 mg (50/10/10) | 49557-75-7 / 137525-51-0 / 77591-33-4 | 403.93 / 1419.53 / 4963.50 g/mol | Extracellular matrix remodeling, VEGFR2 angiogenesis & G-actin motility | Sterile 0.9% Bacteriostatic Water (3.0 mL); gently swirl to clear blue solution | SL-2026-127 ≥99.0% | €98 |
GH Secretagogues & Growth Factor Comparison
GHRH analogues, selective ghrelin (GHS-R1a) mimetics, and recombinant IGF-1/GH reference proteins
| Compound | CAS # | Molecular Weight | Primary Receptor / Mechanism | Solvent | Active Lot / Spec | Unit (EUR) |
|---|---|---|---|---|---|---|
| CJC-1295 (no DAC) 5 mg | 863288-34-0 | 3367.97 g/mol | Pituitary GHRH Receptor (Class B GPCR) | Sterile 0.9% Bacteriostatic Water (1.0–2.0 mL) | SL-2026-116 ≥99.0% | €44 |
| Ipamorelin 5 mg | 170851-70-4 | 711.85 g/mol | Selective Growth Hormone Secretagogue Receptor 1a (GHS-R1a) | Sterile 0.9% Bacteriostatic Water (1.0–2.0 mL) | SL-2026-135 ≥99.2% | €38 |
| Sermorelin 5 mg | 86168-78-7 | 3357.88 g/mol | Pituitary GHRH Receptor (native short-acting reference ligand) | Sterile 0.9% Bacteriostatic Water (1.0–2.0 mL) | SL-2026-156 ≥99.0% | €42 |
| Tesamorelin 5 mg | 218949-48-5 | 5135.77 g/mol | Pituitary GHRH Receptor (full-length stabilized GHRH 1-44 analogue) | Sterile 0.9% Bacteriostatic Water (1.0–2.0 mL) | SL-2026-162 ≥99.0% | €58 |
| IGF-1 LR3 1 mg | 946870-92-4 | 9111.50 g/mol | Insulin-like Growth Factor 1 Receptor (IGF-1R) with reduced IGFBP binding | Pre-dissolve in sterile 0.6% (10 mM) Acetic Acid (0.5–1.0 mL), then dilute with buffered carrier solution | SL-2026-134 ≥99.0% | €68 |
Mitochondrial, Bioenergetic & Longevity Probes
Mitochondrial-derived peptides, cardiolipin stabilizers, redox coenzymes, telomerase peptides, and ERR small molecules
| Compound | CAS # | Molecular Weight | Primary Receptor / Mechanism | Solvent | Active Lot / Spec | Unit (EUR) |
|---|---|---|---|---|---|---|
| MOTS-c 10 mg | 1627580-64-6 | 2174.62 g/mol | Folate-AICAR-AMPK pathway & mitochondrial-nuclear stress signaling | Sterile 0.9% Bacteriostatic Water or neutral PBS (1.0–2.0 mL); minimize air agitation | SL-2026-147 ≥99.0% | €56 |
| SS-31 10 mg | 736992-21-2 | 639.79 g/mol | Inner mitochondrial membrane Cardiolipin & Electron Transport Chain supercomplexes | Sterile 0.9% Bacteriostatic Water or sterile PBS (>10 mg/mL) | SL-2026-159 ≥99.0% | €58 |
| NAD+ 500 mg | 53-84-9 | 663.43 g/mol | Sirtuins (SIRT1–SIRT7), PARPs, CD38 & Mitochondrial Complex I | Sterile PBS (pH 6.0–7.0) or Bacteriostatic Water (adjust pH carefully for cell assays) | SL-2026-148 ≥99.2% | €52 |
| Epitalon 10 mg | 307297-39-8 | 390.35 g/mol | Telomerase (hTERT) expression & pineal circadian gene transcription | Sterile 0.9% Bacteriostatic Water or sterile PBS (pH 7.4) | SL-2026-121 ≥99.0% | €42 |
| SLU-PP-332 5 mg | 303760-60-3 | 290.32 g/mol | Estrogen-Related Receptors ERRα (EC50 98 nM), ERRβ & ERRγ | Sterile DMSO (up to 20–30 mg/mL); insoluble in pure water | SL-2026-157 ≥99.0% | €66 |
| FOXO4-DRI 10 mg | 2460055-10-9 | 5358.13 g/mol | FOXO4–p53 protein–protein interaction (senolytic pathway) | Sterile PBS (pH 7.4) or sterile 0.9% Bacteriostatic Water | SL-2026-123 ≥99.0% | €115 |
Neuropeptides & Cognitive Signaling Comparison
ACTH/tuftsin synthetic heptapeptides, circadian regulators, and VIP/oxytocin receptor ligands
| Compound | CAS # | Molecular Weight | Primary Receptor / Mechanism | Solvent | Active Lot / Spec | Unit (EUR) |
|---|---|---|---|---|---|---|
| Semax 5 mg | 80714-61-0 | 813.92 g/mol | BDNF / TrkB & NGF neurotrophin expression, dopaminergic/serotonergic modulation | Sterile 0.9% Bacteriostatic Water or sterile PBS (pH 7.4) | SL-2026-155 ≥99.0% | €34 |
| Selank 5 mg | 129954-34-3 | 751.87 g/mol | GABA-A allosteric modulation, enkephalinase inhibition & IL-6/BDNF gene expression | Sterile 0.9% Bacteriostatic Water or sterile saline (>10 mg/mL) | SL-2026-153 ≥99.0% | €34 |
| DSIP 5 mg | 62568-57-4 | 848.81 g/mol | GABAergic / NMDA neuromodulatory & HPA-axis pathways | Sterile water, PBS (pH 7.4), or 0.9% Bacteriostatic Water (>10 mg/mL) | SL-2026-120 ≥99.0% | €36 |
| VIP 5 mg | 40077-57-4 | 3325.80 g/mol | VPAC1 & VPAC2 (Class B GPCRs) — neuroimmune & circadian signaling | Sterile 0.9% Bacteriostatic Water or neutral PBS (pH 7.0–7.4) | SL-2026-166 ≥99.0% | €48 |
| Oxytocin 5 mg | 50-56-6 | 1007.19 g/mol | Oxytocin Receptor (OXTR, Gq-coupled GPCR) | Sterile 0.9% Bacteriostatic Water or sterile saline (pH 4.5–6.5) | SL-2026-149 ≥99.0% | €34 |
2026 European & Swiss Research Peptide Supplier Audit Checklist
Following major 2026 European vendor shifts—including UK storefront closures, heightened cross-border customs screening, and widespread complaints over reused certificates—laboratories should audit every peptide supplier against six verifiable operational standards.
| Audit Criterion | Swiss Peptides Benchmark (Verified Standard) | Common Industry Shortcoming / Red Flag |
|---|---|---|
| Analytical Testing Depth | Modality-matched: RP-HPLC + ESI-MS for peptides; SEC-HPLC + SDS-PAGE for recombinant proteins; LAL endotoxin (<0.5 EU/mg) & Karl Fischer moisture (<3.0%). | Generic "99% lab tested" badges without ESI-MS mass confirmation, quantitative Net Peptide Content, or protein-appropriate SEC-HPLC. |
| Batch-to-Vial Traceability | Live searchable 66-lot Batch COA Registry with active lot codes, release dates, and direct lot chromatogram verification by email. | Reused, cropped, or undated static PDF certificates recycled across multiple production batches. |
| Switzerland & EU Customs Architecture | Dedicated Swiss domestic fulfillment (1–2d Free) plus intra-EU customs-cleared lane (2–4d, Free >€150)—eliminating US/Asia and post-Brexit border holds. | Overseas US/Asia dispatches or post-Brexit UK hubs triggering FOCBS/EU customs inspections, duties, or multi-day ambient holds. |
| Cold-Chain & Weekend Discipline | Strict Mon–Thu dispatch (14:00 CET cutoff) in insulated thermal foil with medical-grade coolant gel packs + 14-day transit integrity replacement. | Friday shipping in plain uninsulated envelopes causing 72+ hour ambient courier warehouse exposure. |
| Entity & Support Transparency | Named Zurich entity (SwissLab Peptides AG, Technoparkstrasse 1, 8005 Zurich), direct email support, Zoho LiveChat, and transparent RUO governance. | Anonymous offshore registrations, missing European legal disclosures, bounced support emails, or WhatsApp-only ticketing. |
| Settlement & Procurement Tools | SEPA Bank Transfer (EUR) + 7 Cryptocurrencies (BTC, ETH, USDT, USDC, SOL, XMR), €220 minimum order, plus free Molarity/Sequence pI/Blend Calculator. | Crypto-only checkout gates with zero SEPA banking option and no molecular weight or Net Peptide Content calculation utilities. |
RP-HPLC purity vs. ESI-MS mass identity vs. quantitative Net Peptide Content.
Avoiding post-closure clone scams, offshore opacity, and weekend thermal loss.
FOCBS border boundaries, Swissmedic RUO governance, and intra-EU lanes.
Need Exact Molarity, Sequence pI, or Lot Verification?
Calculate exact reconstitution volumes with Net Peptide Content adjustments, inspect all 66 active lot records, or browse the complete CAS directory.